Poland· PL-100509944
Ofev
A medicinal product containing nintedanibum, registered in Poland by Boehringer Ingelheim International GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Nintedanibum
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991561680
- gtin05909991561697
- gtin05909991561703
- gtin05909991561710
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nintedanibum in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainOFEV 25 MG CAPSULAS BLANDASBoehringer Ingelheim International Gmbh
- FranceOFEV 25 mg, capsule molleBOEHRINGER INGELHEIM INTERNATIONAL
- IcelandOfevBoehringer Ingelheim International GmbH*
- NorwayOfevBoehringer Ingelheim International GmbH
- SwedenOfev 25 mg Kapsel, mjukBoehringer Ingelheim International GmbH
- NetherlandsGevesla 100 mg, zachte capsulesSandoz B.V.
- GermanyNintedanibEugia Pharma (Malta) Limited
- United KingdomNintedanib 100mg capsulesTeva UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Nintedanib Cipla, Nintedanib Ratiopharm
- Belgium · Nintedanib Accordpharma, Nintedanib Eg
- Cyprus · Nintedanib Teva
- Czechia · Nintedanib Glenmark, Nintedanib Sandoz
- Germany · Nintedanib, Nintedanib 1 A Pharma
- Denmark · Nintedanib "sandoz", Nintedanib Glenmark
- Estonia · Agarf, Nintedanib Sandoz
- Spain · Nintedanib, Nintedanib Accordpharma
- Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
- France · Nintedanib Arrow, Nintedanib Biogaran
- United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
- Greece · Nifib, Nindraf
- Croatia · Gevesla, Nintedanib Accordpharma
- Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
- Ireland · Nintedanib Accordpharma, Nintedanib Clonmel
- Iceland · Agarf, Nintedanib Accord
- Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
- Liechtenstein · Nintedanib Accord, Nintedanib Viatris
- Lithuania · Agarf, Nintedanib Sandoz
- Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
- Latvia · Agarf, Nintedanib Sandoz
- Malta · Nifiden Adalvo, Nintedanib Adalvo
- Netherlands · Gevesla, Nintedanair
- Norway · Nintedanib Accord, Nintedanib Devatis
- Portugal · Nintedanib Accordpharma, Nintedanib Eugia
- Romania · Gevesla, Nintedanib Dr. Reddy’s
- Sweden · Nintedanib Devatis, Nintedanib Glenmark
- Slovenia · Nintedanib Accordpharma, Nintedanib Stada
- Slovakia · Nintedanib Stada, Nintedanib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8019629-3280-4c4f-a03a-a83cfca412b6 GET /v1/drugs/a8019629-3280-4c4f-a03a-a83cfca412b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki miękkie",
"source": "urpl",
"strength": "25 mg",
"packaging": "05909991561680 ¦ Rpz ¦ EU/1/14/979/010 ¦ 159508\n60 kaps. (25 mg)\n05909991561697 ¦ Rpz ¦ EU/1/14/979/012 ¦ 159509\n180 kaps. (25 mg)\n05909991561703 ¦ Rpz ¦ EU/1/14/979/009 ¦ 159510\n60 kaps. (25 mg)\n05909991561710 ¦ Rpz ¦ EU/1/14/979/011 ¦ 159511\n120 kaps. (25 mg)",
"substance": "Nintedanibum 25 mg",
"common_name": "Nintedanibum",
"pl_product_id": "100509944",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about nintedanibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.